Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.

We report here the cloning, expression, and characterization of a dual-substrate, cAMP and cGMP, cyclic nucleotide phosphodiesterase (PDE) from mouse. This PDE contains the consensus sequence for a PDE catalytic domain, but shares <50% sequence identity with the catalytic domains of all other known PDEs and, therefore, represents a new PDE gene family, designated PDE10A. The cDNA for PDE10A is 3, 370 nt in length. It includes a full ORF, contains three in-frame stop codons upstream of the first methionine, and is predicted to encode a 779-aa enzyme. At the N terminus PDE10A has two GAF domains homologous to many signaling molecules, including PDE2, PDE5, and PDE6, which likely constitute a low-affinity binding site for cGMP. PDE10A hydrolyzes cAMP with a Km of 0.05 microM and cGMP with a Km of 3 microM. Although PDE10A has a lower Km for cAMP, the Vmax ratio (cGMP/cAMP) is 4.7. RNA distribution studies indicate that PDE10A is expressed at highest levels in testis and brain.

[1]  J. Beavo,et al.  CD3- and CD28-dependent induction of PDE7 required for T cell activation. , 1999, Science.

[2]  K. Matsushima,et al.  Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase. , 1998, Biochemical and biophysical research communications.

[3]  J. Beavo,et al.  Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. , 1998, The Journal of clinical investigation.

[4]  J. Beavo,et al.  Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. A. Murphy,et al.  Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. , 1998, The Journal of urology.

[6]  J. Beavo,et al.  Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases* , 1998, The Journal of Biological Chemistry.

[7]  James F. Smith,et al.  Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase* , 1998, The Journal of Biological Chemistry.

[8]  S. Ballard,et al.  Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. , 1998, The Journal of urology.

[9]  J. Cheng,et al.  Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. , 1998, Biochemical and biophysical research communications.

[10]  C. Ponting,et al.  The GAF domain: an evolutionary link between diverse phototransducing proteins. , 1997, Trends in biochemical sciences.

[11]  J. Beavo,et al.  Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Böck,et al.  Characterization of fhlA mutations resulting in ligand-independent transcriptional activation and ATP hydrolysis , 1997, Journal of bacteriology.

[13]  J. Usukura,et al.  Possible Stimulation of Retinal Rod Recovery to Dark State by cGMP Release from a cGMP Phosphodiesterase Noncatalytic Site* , 1996, The Journal of Biological Chemistry.

[14]  J. Corbin,et al.  Identification of Key Amino Acids in a Conserved cGMP-binding Site of cGMP-binding Phosphodiesterases , 1996, The Journal of Biological Chemistry.

[15]  E. Mardis,et al.  Generation and analysis of 280,000 human expressed sequence tags. , 1996, Genome research.

[16]  R. F. Smith,et al.  BCM Search Launcher--an integrated interface to molecular biology data base search and analysis services available on the World Wide Web. , 1996, Genome research.

[17]  W. K. Sonnenburg,et al.  An Essential Aspartic Acid at Each of Two Allosteric cGMP-binding Sites of a cGMP-specific Phosphodiesterase (*) , 1995, The Journal of Biological Chemistry.

[18]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[19]  V. Arshavsky,et al.  cGMP binding sites on photoreceptor phosphodiesterase: role in feedback regulation of visual transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. K. Sonnenburg,et al.  The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. , 1993, The Journal of biological chemistry.

[21]  M. Boguski,et al.  dbEST — database for “expressed sequence tags” , 1993, Nature Genetics.

[22]  V. Arshavsky,et al.  Noncatalytic cGMP-binding sites of amphibian rod cGMP phosphodiesterase control interaction with its inhibitory gamma-subunits. A putative regulatory mechanism of the rod photoresponse. , 1992, The Journal of biological chemistry.

[23]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[24]  J. Corbin,et al.  Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. , 1990, The Journal of biological chemistry.

[25]  R. Haslam,et al.  Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. , 1990, Molecular pharmacology.

[26]  J. Beavo,et al.  Direct photolabeling of the cGMP-stimulated cyclic nucleotide phosphodiesterase. , 1989, The Journal of biological chemistry.

[27]  M. Bitensky,et al.  Reciprocal effects of an inhibitory factor on catalytic activity and noncatalytic cGMP binding sites of rod phosphodiesterase. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Hansen,et al.  Purification of two calcium/calmodulin-dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Mumby,et al.  Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. , 1982, The Journal of biological chemistry.

[30]  W. Dreyer,et al.  Measurement of protein-binding phenomena by gel filtration. , 1962, Biochimica et biophysica acta.

[31]  K. Nakai,et al.  PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. , 1999, Trends in biochemical sciences.

[32]  G. Lupidi,et al.  3'-5' cAMP phosphodiesterase in pig liver nuclei. , 1990, Italian Journal of Biochemistry.

[33]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases : structure, regulation and drug action , 1990 .

[34]  W. K. Sonnenburg,et al.  Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.